Befejeződött1. fázis
M1774 (oral ATR inhibitor) in Combination with PLX038 (Topo1 inhibitor) with dose expansion cohorts in patients with advanced solid tumors
Key facts
- Where
- Paris és Saint-Cloud, FranciaországSee the 2 sites
- Phase
- 1. fázis
Where in Franciaország
- Institut CurieParis, FranciaországNo longer taking part
- Institut CurieSaint-Cloud, FranciaországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Curie
- Trial code
- EU 2023-505431-12-00
- Record updated
- 2025. december 17.